DMD#7369 1 Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine and sulfinpyrazone) ‘probes’ for human UDP- glucuronosyltransferases Verawan Uchaipichat, Peter I. Mackenzie, David J. Elliot and John O. Miners Department of Clinical Pharmacology, Flinders University and Flinders Medical Centre, Adelaide, Australia DMD Fast Forward. Published on December 28, 2005 as doi:10.1124/dmd.105.007369 Copyright 2005 by the American Society for Pharmacology and Experimental Therapeutics. This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on December 28, 2005 as DOI: 10.1124/dmd.105.007369 at ASPET Journals on October 21, 2022 dmd.aspetjournals.org Downloaded from